In patients with locally advanced rectal cancer who receive neoadjuvant therapy, radiation dose intensification improves pathologic complete response but leads to a small increase in acute toxicities.

ARLINGTON, Va., November 25, 2024 — The American Society for Radiation Oncology (ASTRO) issued today an updated clinical guideline for physicians who use radiation therapy to treat patients with ...

Anal cancer is often linked to HPV, with squamous cell carcinoma being the most common type. Diagnosis involves exams, ...

Dr. Yufei Liu discusses how updates to precision radiation therapy are reshaping colorectal cancer care. As Colorectal Cancer Awareness Month highlights the importance of early detection and ...

Positron Emission Tomography Is Superior to Computed Tomography Scanning for Response-Assessment After Radical Radiotherapy or Chemoradiotherapy in Patients With Non–Small-Cell Lung Cancer Purpose: ...

Seattle — Dec. 18, 2025 — Fred Hutch Cancer Center researchers have developed a new tool that enables anyone to immediately assess their colorectal cancer risk online. Called MyGeneRisk, the free, web ...

Among patients with locally advanced rectal cancer, concurrent chemoradiotherapy did not significantly increase second pelvic malignancies compared to chemotherapy alone, but it did raise the risk for ...

Woman diagnosed with rectal cancer at 29 shares her only symptom, has uterine transposition, a surgery to move her womb ...

Patients with secondary rectal cancer (SRC) after radiotherapy (RT) for prostate cancer have shorter survival compared with matched treatment-naïve patients, (1) but factors explaining this gap have ...

In most solid tumors, high numbers of regulatory T (Treg) cells are associated with poorer outcomes because they dampen the ...

Our Care Advisors will connect you with the best healthcare provider for your needs. Finding the right cancer care team can be stressful. Your team of rectal cancer experts will ask about your ...